Growth Metrics

Insulet (PODD) Net Cash Flow (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -456.67%
Dec 31, 2025 88.41%
Sep 30, 2025 -112.74%
Jun 30, 2025 -152.26%
Mar 31, 2025 455.20%
Dec 31, 2024 -23.87%
Sep 30, 2024 9.05%
Jun 30, 2024 42.83%
Mar 31, 2024 213.29%
Dec 31, 2023 -40.38%
Sep 30, 2023 9.96%
Jun 30, 2023 144.88%
Mar 31, 2023 -2.87%
Dec 31, 2022 -376.19%
Sep 30, 2022 950.00%
Jun 30, 2022 102.22%
Mar 31, 2022 -27.60%
Dec 31, 2021 -1,609.52%
Sep 30, 2021 -88.10%
Jun 30, 2021 140.95%
Mar 31, 2021 -210.80%
Dec 31, 2020 35.54%
Sep 30, 2020 -90.06%
Jun 30, 2020 6,377.17%
Mar 31, 2020 95.61%
Dec 31, 2019 -169.49%
Sep 30, 2019 3,341.94%
Jun 30, 2019 -159.62%
Mar 31, 2019 230.43%
Dec 31, 2018 -23.68%
Sep 30, 2018 85.47%
Jun 30, 2018 3.73%
Mar 31, 2018 -140.56%
Dec 31, 2017 497.68%
Sep 30, 2017 1,137.29%
Jun 30, 2017 95.51%
Mar 31, 2017 21.65%
Dec 31, 2016 -155.87%
Sep 30, 2016 488.63%
Jun 30, 2016 -219.81%
Mar 31, 2016 50.54%
Dec 31, 2015 -4,234.55%
Sep 30, 2015 216.77%
Jun 30, 2015 91.57%
Mar 31, 2015 -215.85%
Dec 31, 2014 116.53%
Sep 30, 2014 -197.47%
Jun 30, 2014 827.72%
Mar 31, 2014 1.56%
Dec 31, 2013 -241.10%
Sep 30, 2013 2.85%
Jun 30, 2013 -96.83%
Mar 31, 2013 1,575.97%
Dec 31, 2012 8.22%
Sep 30, 2012 47.90%
Jun 30, 2012 -17.47%
Mar 31, 2012 -11.08%
Dec 31, 2011 -235.96%
Sep 30, 2011 -229.94%
Jun 30, 2011 125.70%
Mar 31, 2011 -193.91%
Dec 31, 2010 166.11%